The largest database of trusted experimental protocols

Dyssomnias

Dyssomnias are a group of sleep disorders characterized by difficulty falling asleep, staying asleep, or experiencing poor sleep quality.
These conditions can lead to daytime fatigue, decreased cognitive function, and impaired quality of life.
PubCompare.ai helps researchers optimize their dyssomnia research by locating the best protocols from scientific literature, preprints, and patents.
Our AI-driven platform enables comparision and analysis of data to identify the most effective treatments and products for these sleep disorders.
Get more from your dyssomnia research with the power of PubCompare.ai.

Most cited protocols related to «Dyssomnias»

The “full” SD and SRI item banks consisted of 27 and 16 items each. Respondents rated various aspects of their sleep over the past 7 days on 5-point scales. Most of the items used an intensity scale (not at all, a little bit, somewhat, quite a bit, very much), with a smaller number using a frequency scale (never, rarely, sometimes, often, always), and one item (S109) assessing overall sleep quality using a scale of very poor, poor, fair, good, very good. Items assessing sleep disturbance or sleep-related impairment were scored 1 to 5 with 1 for the lowest category (i.e., not at all) and 5 for the highest category (i.e., very much). In order to be consistent with PROMIS conventions, some items were reverse scored so that, for all items, higher scores corresponded to greater sleep disturbance or sleep-related impairment. Participants also completed two commonly used measures for comparative analyses, the PSQI and the ESS. The PSQI was scored based on standard procedures, with 7 component scores summed together to yield a global score with a range of 0 (good sleep quality) to 21 (poor sleep quality); only the component scores were considered in IRT analyses. The ESS contains 8 items with 4 response categories for each item. ESS items are scored 0 to 3 with 0 for the lowest category and 3 for the highest category. The score for the ESS is obtained by summing the 8 items, and has a range of 0 (no propensity for dozing during daytime activities) to 24 (high propensity for dozing during daytime activities). Demographic and global health information including global health and fatigue items were also collected, as described in Buysse et al (2010) (link).
Publication 2011
Conferences Dyssomnias Fatigue Sleep
The ISI comprises seven items that evaluate difficulty falling asleep and staying asleep, problems waking up too early, satisfaction with current sleep patterns, interference with daily functions, noticeability of impairment attributed to sleep problems, and distress caused by the sleep problem. Each of the ISI items is rated on a scale of 0-4; the total score ranges from 0 to 28, with a higher score indicating greater insomnia severity. The total ISI scores are divided into four subcategories: 0-7, no clinically significant insomnia; 8-14, subthreshold insomnia; 15-21, moderate insomnia; and 22-28, severe insomnia. A cutoff score of 15 has been used as the threshold for clinically significant insomnia, and a score below 8 has been used to define remission after treatment (i.e., no longer meets the criteria for insomnia).28 (link)
Linguistic validation was achieved by having two sleep specialists translate the original ISI questionnaire into Korean; the Korean version was then translated back into English by one sleep specialist and one linguist, both of whom were fluent in Korean and English. Comparison of the original ISI with the final back-translated version was performed by individuals who were fluent in both languages and who were not involved in the research study. The final ISI-K was obtained after completion of these standard procedures.
Publication 2014
Aftercare Dyssomnias Koreans Satisfaction Sleep Sleeplessness
Item response data for the SD and SRI item banks were obtained from an internet (YouGov Polimetrix) sample and a clinical sample at the University of Pittsburgh Medical Center. YouGov Polimetrix is a national, web-based polling firm based in Palo Alto, CA. YouGov Polimetrix customized the sample to include individuals with various health conditions (Polimetrix, 2006 ).
The YouGov Polimetrix sample consisted of 1,993 respondents (41% women, 11% Hispanic, 16% minority, and mean age [S.D.] 52 [15.9]), including 1,259 adults from the general population without self-reported sleep problems, and 734 with self-reported sleep problems. Sleep problems were identified by self report with 4 branching questions: “Have you ever been told by a doctor or health professional that you have a sleep disorder?” “What type of sleep disorder (with 13 options)?” “Has your sleep disorder been treated?” and “Did the treatment help you?”. In order to have adequate observations of each response category for each item, especially for response categories indicating high severity, a separate clinical sample was added to enrich the Polimetrix sample and included 259 patients with sleep problems obtained from sleep medicine clinics in psychiatry and general medicine (61% women, 2% Hispanic, 30% minority, mean age [S.D.] 44 [13.8]). In aggregate, the Polimetrix sample of 1, 993 participants plus the clinical sample of 259 participants, the final pooled sample included 2, 252 participants. For a detailed description of this pooled sample, see Buysse et al. (2010) (link).
Publication 2011
Adult Dyssomnias Health Care Professionals Hispanics Hypersomnia Minority Groups Patients Physicians Sleep Disorders Woman

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
Anxiety Committee Members Dyssomnias Fatigue MAP protocol Mental Health Pain Pain Measurement Physicians Satisfaction Severity, Pain Vaginal Diaphragm
The CAM-S is intended to be used in addition to the original CAM algorithm; that is, the CAM-S will not yield a delirium diagnosis, only a means to quantify the intensity of delirium symptoms observed at the bedside. These symptoms can be present in persons both with and without delirium. We created a short-form and long-form of the CAM-S scoring system. The short form was based on the four features from the CAM diagnostic algorithm (7 ) which can be rated at the bedside: acute onset or symptom fluctuation, inattention, disorganized thinking, and altered level of consciousness. Each symptom of delirium--except fluctuation--was rated as absent (0), mild (1) or marked (2). Acute onset or fluctuation was rated as absent (0) or present (1). The sum of these ratings yielded a CAM-S short form severity score ranging from 0 to7 (7 = most severe). The long form was based on the 10 features from the full CAM instrument (8 (link)): acute onset or symptom fluctuation, inattention, disorganized thinking, altered level of consciousness, disorientation, memory impairment, perceptual disturbances, psychomotor agitation, psychomotor retardation, and sleep-wake cycle disturbance. Each symptom was rated 0-2, except for acute onset or fluctuation, as previously described. The sum of these ratings yielded a CAM-S long form score from 0 to 19 (19 = most severe). Features scored as “uncertain” did not contribute to the severity score. Uncertain ratings were present for one or more items in only 13/1456 (< 1%) CAM-S short form items and 38/1456 (< 3%) CAM-S long form items.
Publication 2014
Delirium Diagnosis Dyssomnias Memory Deficits

Most recents protocols related to «Dyssomnias»

The PROMIS-57 was used to assess symptoms in this study. The scale consists of 57 items clustered into seven domains: anxiety, depression, fatigue, sleep disturbance, pain interference and intensity, physical function, and ability to participate in social roles and activities [12 (link)]. Each item was scored on a five-point Likert scale, except for pain intensity with one item, which was scored between 0 and 10 (least to most severe) [13 (link)]. Raw scores varied from 8 to 40 in each domain and were derived as per the PROMIS scoring manual into T-scores with a mean of 50 and a standard deviation (SD) of 10. Higher scores indicated a higher level of functioning or greater symptom severity. An acceptable internal consistency for the scale was found in this sample (α ranged from 0.87 to 0.97).
Full text: Click here
Publication 2023
Anxiety Dyssomnias Fatigue Pain Physical Examination Severity, Pain
In preparation for our cluster analyses, all sleep variables were mean-centred and scaled such that higher scores indicated better sleep. We then used K-means cluster analysis to characterize subgroups of sleep variables in WRAP participants (n = 619), conducted using ‘factoextra’ package in R.64 The cluster assignment was based on the minimum distance (sum of the deviation of each variable) of a participant from the centroid of the cluster. The optimal number of clusters was identified using the elbow method by looking at the total within-cluster sum of square (WSS). To characterize the sleep group for each clustering-based subgroup of participants, the effect size ( ε2 ) of the sleep problems used in cluster analysis was noted in the right column of Supplementary Table 3. The relative contributions of the different problems in the grouping of participants were large, medium and small when ε2 ≥ 0.26, ε2 ≥ 0.08 and ε2 ≥ 0.01, respectively.65 Given the high correlation among sleep variables, we conducted preliminary cluster analyses, sequentially excluding subsets of the scales and examining fit statistics and consistency across solutions. Based on the best WSS and Calinski–Harabasz Index values, the following subset of scales was selected in primary analyses: SPI1, SDS, ADQ, SOM, self-reported sleep duration, ESS and ISI.
To characterize how sleep groups differed across sleep characteristics, we used chi-square for categorical variables and Kruskal–Wallis tests for Likert-scale variables [median (Q1–Q3) reported]. Post hoc pairwise group differences at unadjusted P < 0.05 were reported.
Three sensitivity analyses were conducted to investigate the consistency of sleep group assignments and to examine whether between sleep group patterns in our outcomes were stable across different sample selection criteria. Alternative 1: we used LPA to characterize sleep subgroups (‘Mclust’ package in R). Briefly, LPA was a data-driven approach using continuous variables and indicators to identify subgroups of individuals. In this statistical approach, subgroup membership was determined by examining the pattern of interrelationships among indicator variables (maximizing homogeneity within each subgroup and heterogeneity between subgroups).66 Alternative 2 (cognitively unimpaired subset only): we reduced the original set to include only those who were cognitively unimpaired (n = 21 with mild cognitive impairment were removed; leaving n = 598), and K-means cluster analysis was used in this subset. Alternative 3 (expanded set with imputed ISI): as previously noted, the primary cluster analysis was based on the first visit with MOS, ESS and ISI. Since the MOS and ESS questionnaires were added to the battery several years before the ISI, we opted to enlarge ‘baseline sleep’ in sensitivity analyses to include those who had not yet completed an ISI but had completed MOS and ESS at least once. The imputation method used the sleep data on a person both before and after the ‘missing value’. The next observation carried backward assigned the person’s next known sleep score after the ‘missing’ one to the ‘missing value’. If the person did not have the next value, the last observation carried forward, assigned the person’s last previous known sleep score to the ‘missing value’, was used.67 (link) The resulting enlarged set included n = 1237 available.
Full text: Click here
Publication 2023
Cognitive Impairments, Mild Dyssomnias Elbow Genetic Heterogeneity Hypersensitivity Sleep SPI1 protein, human
This scale comprises 12 questions about the past 4 weeks, from which eight scores were computed.44 The first question asks how long it takes to fall asleep, with possible responses in 15-min increments ranging from 1 = ‘0–15 minutes’ to 5 =‘More than 60 minutes’.44 The second question asks the average number of hours slept each night, which is entered freely.44 Responses to the remaining 10 questions are on a 6-point scale ranging from 1 = ‘all of the time’ to 6 = ‘none of the time’.44 Responses are summed to give scores for six sleep domains: SDS, somnolence (SOM), sleep adequacy (ADQ), snoring, awaking short of breath or with a headache, and two indices of sleep problems summarizing six (Index I) (SPI1) or nine (Index II) (SPI2) items.45 Multi-item scores show good internal consistency, with Cronbach’s alpha 0.71 to 0.81.46 (link)Supplementary Table 1 indicates which items contribute to each score, with some items contributing to more than one score. We define people to have the optimal sleep if 7 h ≤self-reported sleep duration ≤8.47 (link)
Full text: Click here
Publication 2023
Dyssomnias Headache Sleep Somnolence SPI1 protein, human
All mothers deemed eligible to participate will be invited to complete a series of questionnaires via RedCap to assess baseline data of interest before allocation. See Table 2 for specific questionnaires.

Schedule for assessment administration

Study period
TIMEPOINTEnrolmentAllocationInterventionPost-interventionFollow-up
Weeks 1–8Week 9Weeks 9–19vWeeks 19–21Weeks 32–34
Adverse Childhood ExperiencesaX
Ages and Stages Questionnaire: Social-Emotional, Second Edition(6, 12, 18, 24, 30, 36 months)bXXX
Alcohol Use Disorder Identification TestcXXX
Anxiety Persistence ScaleaX
BEAMd App-Based QuestionnaireaX
BEAMd Forum QuestionnaireaX
BEAMd Perceived Social Support QuestionnaireaX
BEAMd Zoom Telehealth Group QuestionnaireaX
Cannabis, Tobacco, and Illicit Drug UseaXXX
Cannabis Use Disorder Identification Test – RevisedeXXX
Couples Satisfaction Index – 4 ItemfXXX
Depression Persistence ScaleaX
Depressive Symptom Index – Suicidality SubscalegXX
Emergency Health & Social Service UtilizationaXXX
Generalized Anxiety Disorder – 2 ItemhX
Generalized Anxiety Disorder – 7 ItemiXXX
Infant Behavior Questionnaire – Very Short – RevisedjXXX
mHealth App Usability QuestionnairekX
Mini International Neuropsychiatric InterviewlX
Mood Mission App-Based QuestionnaireX
Parenting Scale(modified 10 item scale)mXX
Parenting Stress IndexnXXX
Parenting Stress Index(modified 4 item scale)aX
Patient Health Questionnaire – 2 ItemoX
Patient Health Questionnaire – 9 ItempXXX
Patient-Reported Outcomes Measurement Information System(Anger and Sleep Disturbance Subscales)qXXX
Pediatric Quality of Life Inventory(1–12 or 13–24 months)r,sXXX
Perceived Maternal Parenting Self-Efficacy QuestionnairetXXX
Positive and Negative Affect Scale(modified 2-item scale)uX
Recent Stressful ExperiencesaXXX
SociodemographicsaX
Substance Use Motives Measure(Coping Motive Subscales)vXXX

Note. aAuthor-Compiled Questionnaire; bSquires et al. (2015)cBabor et al. (2001)dBEAM = Building Emotional Awareness and Mental healtheAdamson & Sellman (2003)fFunk & Rogge (2007) gStanley et al. (2021)hKroenke et al. (2007)ISpitzer et al. (2006) jIBQ-VS-R (Putnam et al., 2014) kZhou et al. (2019) lSheehan et al. (1998) mIrvine et al. 1999 nBarroso et al. (2016) oKroenke et al. (2003) pKroenke et al. (2001) qPROMIS (Hanish et al., 2017; Pilkonis et al., 2011) rPhysical Functioning, Physical Symptoms, Emotional Functioning, Social Functioning, and Cognitive Functioning Subscales sVarni et al. (1999) tBarnes & Adamson-Macedo (2007) uWatson et al. (1988) vBiolcati & Passini (2019); vWeekly questionnaires are only administered to those in the BEAM program

Full text: Click here
Publication 2023
Anger Awareness Behavior Disorders Dyssomnias Emotions Illicit Drugs Mothers Motivation Phobia, Social Physical Examination Satisfaction Telemedicine Tobacco Products
Data on maternal depression (PHQ-9) and anxiety (GAD-7) will be used to estimate effect size for a future large-scale RCT and to assess preliminary mean change in variables of interest across assessment timepoints. The PHQ-9 includes [35 (link)] nine items which will ask mothers the severity of their depressive symptoms during the past 2 weeks. The PHQ-9 has high internal consistency (α = 0.88) [49 (link)]. Anxiety symptom severity will be assessed using the GAD-7, a seven-item measure which will ask mothers their degree of anxiety symptoms over the past 2 weeks. The GAD-7 has excellent internal consistency (α = 0.92) [36 (link)]. Items on both scales are scored on a 4-point Likert scale ranging from 0 (“Not at all”) to 3 (“Nearly every day”) where higher summative scores suggest more problematic symptoms.
Additional questionnaires will assess maternal mental health (i.e., Patient Reported Outcomes Measurement Information System [PROMIS] Anger [PROMIS-A] [50 (link)] and Sleep Disturbance [PROMIS-SD] [51 (link)] subscales, Alcohol Use Disorder Identification Test [AUDIT] [52 ] Cannabis use Disorder Identification Test – Revised [CUDIT-R] [53 (link)], Substance Use Motives Measure—Coping Subscales [SUMM] [54 (link)], and Depression Severity Index—Suicidality Subscale [DSI-SS] [43 (link)]), parenting (i.e., Parenting Stress Index – Short Form [PSI-SF] [40 (link)], Perceived Maternal Parenting Self-Efficacy [PMP S-E] [55 (link)], and the Parenting Scale—Overreactivity Subscale [56 ], Couples Satisfaction Inventory 4-Item [CSI-4] [57 (link)]), and child outcomes (i.e., Ages and Stages Questionnaire: Social-Emotional Challenges – 2 [ASQ:SE-2] [58 ], Pediatric Quality of Life Inventory [PedsQL] [59 (link)], and Infant Behavior Questionnaire – Revised – Very Short Form—Effortful Control Subscale [IBQ-R-VS] [60 (link)]).
Data on sociodemographic characteristics will be collected in the pre- and/or post-intervention questionnaires including (a) maternal demographics (e.g., age, marital status, highest level of education, ethnicity, employment, depression persistence, anxiety persistence), (b) child demographics (e.g., child sex, age of child), and (c) household demographics (e.g., number of adults and children in the household, annual household income, community type).
Other variables known to impact adult mental health and child development will be collected including the Adverse Childhood Experiences (ACEs) Questionnaire, the author-compiled Recent Stressful Experiences Questionnaire (RSE; developed based on recommendations from the JPB research network on toxic stress at Harvard’s Center on the Developing Child) [61 ], and the author-compiled Emergency Health and Social Service Utilization Questionnaire.
Full text: Click here
Publication 2023
Adult Alcohol Use Disorder Anger Anxiety Cannabis Child Child Development Depressive Symptoms Dyssomnias Emergencies Emotions Ethnicity Forms Control Households Mental Health Mothers Motivation Satisfaction Substance Use

Top products related to «Dyssomnias»

Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Japan, United Kingdom, Austria, Germany, Czechia, Belgium, Denmark, Canada
SPSS version 22.0 is a statistical software package developed by IBM. It is designed to analyze and manipulate data for research and business purposes. The software provides a range of statistical analysis tools and techniques, including regression analysis, hypothesis testing, and data visualization.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Denmark, Czechia, Belgium, Sweden, New Zealand, Spain
SPSS version 25 is a statistical software package developed by IBM. It is designed to analyze and manage data, providing users with a wide range of statistical analysis tools and techniques. The software is widely used in various fields, including academia, research, and business, for data processing, analysis, and reporting purposes.
Sourced in United States, Japan, United Kingdom, Germany, Austria, Canada, Belgium, Spain
SPSS version 26 is a statistical software package developed by IBM. It is designed to perform advanced statistical analysis, data management, and data visualization tasks. The software provides a wide range of analytical tools and techniques to help users understand and draw insights from their data.
Sourced in United States, Austria, United Kingdom, Cameroon, Belgium, Israel, Japan, Australia, France, Germany
SAS v9.4 is a software product developed by SAS Institute. It is a comprehensive data analysis and statistical software suite. The core function of SAS v9.4 is to provide users with tools for data management, analysis, and reporting.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, China
SPSS Statistics version 21 is a statistical software package developed by IBM. It is designed for data analysis and management, providing tools for data exploration, modeling, and reporting. The software offers a range of statistical techniques and is widely used in academic and professional research settings.
Sourced in United States, United Kingdom, Austria, Denmark
Stata 15 is a comprehensive, integrated statistical software package that provides a wide range of tools for data analysis, management, and visualization. It is designed to facilitate efficient and effective statistical analysis, catering to the needs of researchers, analysts, and professionals across various fields.
Sourced in United States, Denmark, United Kingdom, Belgium, Japan, Austria, China
Stata 14 is a comprehensive statistical software package that provides a wide range of data analysis and management tools. It is designed to help users organize, analyze, and visualize data effectively. Stata 14 offers a user-friendly interface, advanced statistical methods, and powerful programming capabilities.
Sourced in United States, Denmark, United Kingdom, Austria, Sweden
Stata 13 is a comprehensive, integrated statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and graphical capabilities. Stata 13 is designed to handle complex data structures and offers a variety of statistical methods for researchers and analysts.

More about "Dyssomnias"

Dyssomnias, also known as sleep disorders, are a group of conditions characterized by difficulties with falling asleep, staying asleep, or experiencing poor sleep quality.
These issues can lead to daytime fatigue, decreased cognitive function, and impaired quality of life.
Insomnia, sleep apnea, and narcolepsy are common types of dyssomnias.
Insomnia involves difficulty initiating or maintaining sleep, while sleep apnea is marked by repeated pauses in breathing during sleep.
Narcolepsy is a neurological disorder that causes excessive daytime sleepiness and sudden attacks of sleep.
PubCompare.ai is an AI-driven platform that can help optimize dyssomnia research by locating the best protocols from scientific literature, preprints, and patents.
Researchers can use the tool to compare and analyze data, identifying the most effective treatments and products for these sleep disorders.
Statistical software like SAS 9.4, SPSS version 22.0, Stata 15, and others can be leveraged to rigorously analyze data related to dyssomnias and sleep disorders.
These programs offer advanced analytical capabilities to uncover insights and drive research forward.
With the power of PubCompare.ai and leading statistical tools, researchers can get more from their dyssomnia studies and improve our understanding of these challenging sleep conditions.